This week we are hosting our annual MedCity INVEST conference online. Today is the last session of the event and includes the diagnostics track of the Pitch Perfect contest. The conference kicked off July 20. You can check out the agenda here.
At 3:30 p.m. five diagnostics startups will present their technologies in the final track of the week long Pitch Perfect competition in which healthcare startups pitch to a team of investor judges who question them about their businesses. They include:
SEngine leverages the convergence of modern technologies and functional precision medicine in the form of the PARIS Test, to deliver more effective, less toxic treatments to cancer patients and accelerate development of novel therapeutics.
CEO: Carla Grandori MD, PhD
Headquarters: Seattle, WA
Exogene Bio is a diagnostics and medical device company whose goal is to enter the liquid biopsy market in order to simultaneously isolate exosomes and cell-free biomarkers using proprietary nanofluidic technology. This technology will then be integrated into an automated medical diagnostic device for the simultaneous detection of multiple classes of cancers using early stage biomarkers contained within exosomes and in cell-free fractions of body fluids.
CEO: Anant Kamath
Headquarters: Iowa City, IA
Amplified Sciences is a molecular diagnostics company using ultra-sensitive molecular sensing technology with composition of matter IP. The first application – early detection of pancreatic cancer – is an assay that will quickly prove the investment thesis due to large unmet medical need and a favorable reimbursement path.
CEO: Diana Caldwell
Headquarters: Indianapolis, IN
Atom Bioworks is a pioneer and leader in practice PEST (Pattern-matching Enabled Sensing & Theraputics) medicine by creating nanoscale biosensing and theraputics platform powered by innovative DNA nanostructures.
CEO: Sherwood Yao
Headquarters: Cary, NC
Genomtec develops smartphone-size, fully automated genetic analyser based on patent pending optical heating technology. It can be utilized in 15-minute infection or mutation detection in personalized therapy.
CEO: Miron Tokarski
Headquarters: Wroclaw, Poland
The judges for the diagnostics track include:
Navneet Alag, H.I.G. BioHealth Partners Vice President
Sean Cheng, Ph.D., Philips Ventures Investment Manager
Derek Mazur, Sante Ventures Senior Associate
Check out participants in the Pitch Perfect competition here. Winners for each track will be announced on July 27 on our website.
All the sessions will be recorded and be available to attendees upon request.
We will be doing more online events this year. Check our events page for updates to the agendas.
For questions about INVEST, contact Laura Kittredge: [email protected]
Photo: Adam Taylor, Getty Images
